Oncology

Tumor Mutational Burden Predicts Survival In Patients With Low Grade Gliomas Expressing Mutated IDH1
Mahmoud Alghamri, Rohit Thalla, Ruthvik Avvari, Ali Dabaja, Ayman Taher, Lilli Zhao, Maria G Castro, Pedro Lowenstein

medRxiv 2020.01.20.20016766; doi: https://doi.org/10.1101/2020.01.20.20016766
Venous Thromboembolism and Intracranial Hemorrhage in Patients with High-grade Glioma
Clara Borges, Carlota Lemos, Pedro Soares, Roberto Silva, Catarina Fernandes, Andreia Costa, Claudia Caeiro, Cristina Sarmento

medRxiv 2020.01.17.20017475; doi: https://doi.org/10.1101/2020.01.17.20017475
Prognostic and Predictive Factors for Primary Chemotherapy in Locally Advanced Breast Cancer
Clara Borges, Daniela Almeida, Margarida Damasceno

medRxiv 2020.01.14.20017467; doi: https://doi.org/10.1101/2020.01.14.20017467
Immune-checkpoint engagement as predictive biomarkers in clear cell renal cell carcinoma and melanoma
Lissete Magraner Sanchez, James Miles, Claire Baker, Christopher J Applebee, Dae-Jin Lee, Somaia Elsheikh, Shaimaa Lashin, Katriona Withers, Andrew Watts, Richard Parry, Christine Edmead, Jose Ignacio Lopez, Raj Mehta, Stephen G Ward, Peter J Parker, Banafshe Larijani

medRxiv 2020.01.15.20017517; doi: https://doi.org/10.1101/2020.01.15.20017517
Prospective Single Center Cohort Study for Early Diagnosis of Cardiac Dysfunction in Swiss Childhood Cancer Survivors: A Study Protocol
Christina Schindera, Claudia Elisabeth Kuehni, Mladen Pavlovic, Eva Haegler-Laube, Nicolas Waespe, Jochen Roessler, Thomas Martin Suter, Nicolas Xavier von der Weid

medRxiv 2020.01.10.20017152; doi: https://doi.org/10.1101/2020.01.10.20017152
Optimizing Clinical Outcome and Toxicity in Lung Cancer Using a Genomic Marker of Radiosensitivity
Jacob G Scott, Geoffrey Sedor, Michael W Kattan, Jeffrey Peacock, G. Daniel Grass, Eric A Mellon, Ram Thapa, Michael Schell, Anthony Waller, Sean Poppen, George Andl, Steven Eschrich, Thomas Dilling, William Dalton, Louis Harrison, Tim Fox, Javier Torres-Roca

medRxiv 2020.01.09.20017046; doi: https://doi.org/10.1101/2020.01.09.20017046
Expanding cancer predisposition genes with ultra-rare cancer-exclusive human variations
Roni Rasnic, Nathan Linial, Michal Linial

medRxiv 2020.01.09.19015867; doi: https://doi.org/10.1101/2020.01.09.19015867
Molecular Profiling of Breast Cancer Susceptibility of Obese or Insulin-Resistant and Pre-Diabetic Patients Using ITLN1 and CD295 SNPs
Nadia M Hamdy, Reham A El-Shemy

medRxiv 2020.01.08.20016980; doi: https://doi.org/10.1101/2020.01.08.20016980
Efficacy and Safety of PD-1/PD-L1 plus CTLA-4 antibodies +/- Other Therapies in Lung Cancer: A Systematic Review and Meta-Analysis
xiong bin

medRxiv 2020.01.08.20016915; doi: https://doi.org/10.1101/2020.01.08.20016915
Surgical candidacy and treatment uptake among women with cervical cancer at public referral hospitals in Kampala, Uganda
Megan Swanson, Nakalembe MIRIAM, Lee-may Chen, Stefanie Ueda, Jane Namugga, Carol Nakisige, Megan J Huchko

medRxiv 2019.12.31.19016279; doi: https://doi.org/10.1101/2019.12.31.19016279

Oncology

Pages